DK0496973T3 - Porcine somatotropiner med ændringer i alfa-helix 1 regionen og kombinationer med andre mutationer. - Google Patents

Porcine somatotropiner med ændringer i alfa-helix 1 regionen og kombinationer med andre mutationer.

Info

Publication number
DK0496973T3
DK0496973T3 DK91120396.6T DK91120396T DK0496973T3 DK 0496973 T3 DK0496973 T3 DK 0496973T3 DK 91120396 T DK91120396 T DK 91120396T DK 0496973 T3 DK0496973 T3 DK 0496973T3
Authority
DK
Denmark
Prior art keywords
helix
alpha
mutations
somatotropins
combinations
Prior art date
Application number
DK91120396.6T
Other languages
Danish (da)
English (en)
Inventor
Meir Fischer
Michael Richard Lebens
Deborah Tardy Chaleff
Original Assignee
American Cyanamid Co
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co, Bio Technology General Corp filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0496973T3 publication Critical patent/DK0496973T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Secondary Cells (AREA)
  • Mold Materials And Core Materials (AREA)
  • Battery Electrode And Active Subsutance (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK91120396.6T 1990-11-30 1991-11-28 Porcine somatotropiner med ændringer i alfa-helix 1 regionen og kombinationer med andre mutationer. DK0496973T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62165690A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
DK0496973T3 true DK0496973T3 (da) 1998-05-04

Family

ID=24491070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91120396.6T DK0496973T3 (da) 1990-11-30 1991-11-28 Porcine somatotropiner med ændringer i alfa-helix 1 regionen og kombinationer med andre mutationer.

Country Status (20)

Country Link
US (1) US5548068A (no)
EP (1) EP0496973B1 (no)
JP (1) JPH05105634A (no)
KR (1) KR100193005B1 (no)
AT (1) ATE163045T1 (no)
CA (1) CA2056467C (no)
DE (1) DE69128877T2 (no)
DK (1) DK0496973T3 (no)
ES (1) ES2112847T3 (no)
FI (1) FI104489B (no)
GR (1) GR3026761T3 (no)
HU (1) HU215947B (no)
IE (1) IE914153A1 (no)
IL (1) IL100169A0 (no)
NO (1) NO301235B1 (no)
NZ (2) NZ240718A (no)
PT (1) PT99648B (no)
SG (1) SG49702A1 (no)
TW (1) TW198040B (no)
ZA (1) ZA919453B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006079A (en) * 1997-06-13 1999-12-21 Motorola, Inc. Radio having a fast adapting direct conversion receiver
TR200504220T2 (tr) 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
GB2384001B (en) * 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
CA2498319A1 (en) * 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
EP2311481A3 (en) 2006-10-20 2013-10-16 Biogen Idec MA Inc. Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
US8637452B2 (en) * 2011-02-23 2014-01-28 Massachusetts Institute Of Technology Water soluble membrane proteins and methods for the preparation and use thereof
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355460B1 (en) * 1988-08-24 2000-12-27 American Cyanamid Company Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis or chemical derivatization
EP0397834B1 (en) * 1988-10-28 2000-02-02 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants

Also Published As

Publication number Publication date
NO914724L (no) 1992-06-01
US5548068A (en) 1996-08-20
HUT62327A (en) 1993-04-28
SG49702A1 (en) 1998-06-15
GR3026761T3 (en) 1998-07-31
AU8830091A (en) 1992-06-04
PT99648B (pt) 1999-05-31
NZ260103A (en) 1996-10-28
DE69128877D1 (de) 1998-03-12
EP0496973B1 (en) 1998-02-04
ES2112847T3 (es) 1998-04-16
ATE163045T1 (de) 1998-02-15
IE914153A1 (en) 1992-06-03
FI915654A0 (fi) 1991-11-29
TW198040B (no) 1993-01-11
ZA919453B (en) 1992-08-26
NZ240718A (en) 1996-10-28
KR920009413A (ko) 1992-06-25
HU913723D0 (en) 1992-02-28
KR100193005B1 (ko) 1999-06-15
DE69128877T2 (de) 1998-06-18
HU215947B (hu) 1999-03-29
NO914724D0 (no) 1991-11-29
AU662493B2 (en) 1995-09-07
FI104489B (fi) 2000-02-15
IL100169A0 (en) 1992-08-18
FI915654A (fi) 1992-05-31
NO301235B1 (no) 1997-09-29
PT99648A (pt) 1992-10-30
EP0496973A3 (en) 1993-02-24
CA2056467A1 (en) 1992-05-31
CA2056467C (en) 1998-07-07
EP0496973A2 (en) 1992-08-05
JPH05105634A (ja) 1993-04-27

Similar Documents

Publication Publication Date Title
DK105892A (da) Dna-sekvens, der koder for et modificeret human-beta-interferonprotein (ifn-beta), hvori 17-cysteinresten er udeladt eller udskiftet med en anden aminosyrerest, ekspressionsvektor indeholdende dna-sekvensen, vaertcelle eller -organisme transformeret med ekspressionsvektoren samt fremgangsmaade til fremstilling af det modificerede protein.
PL274485A1 (en) Method of obtaining stable preparations of human proteins
DK382786D0 (da) Overfladeaktivt rekombinant-alveolarprotein
ATE417057T1 (de) Mutierte formen des fas liganden und deren verwendung
FI102075B1 (fi) Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
DK0496973T3 (da) Porcine somatotropiner med ændringer i alfa-helix 1 regionen og kombinationer med andre mutationer.
NO914720L (no) Somatotropiner med forandringer i alfa-spiral-3-omraadet, alfa-spiral-2-omraadekombinasjoner derav og i kombinasjon medandre mutasjoner
DE3850654T2 (de) Immunglobulin-e-kompetitor.
IL102346A0 (en) Cysteine depleted il-6 muteins
EP0315118A3 (en) Dna coding for endothelin and use thereof
EP0300487A3 (en) Enzymatically inactive, immunologically active beta-galactosidase muteins
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.